In a lab in the heart of Boston, professor Bree Aldridge leads a team of researchers trying to understand a threat that is ...

More information: Chanchal Sur Chowdhury et al, Type I IFN-mediated NET release promotes Mycobacterium tuberculosis ...

With the hope of contributing new knowledge that could help in the development of future medications, UTSA’s researchers are trying to learn more about the qualities of an enzyme called CYP121, which ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...

Different types of immune cells form, so-called granulomas, in which M. tuberculosis can survive for years (latent infection). They fall into a permanently inactive state with reduced metabolic ...

Tuberculosis (TB) continues to be a major global health issue, resulting in millions of new cases and fatalities annually. It is primarily caused by the Mycobacterium tuberculosis (MTB ...